Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 June 2022 | Story Lacea Loader
UFS drops wearing of masks on campus

The management of the University of the Free State (UFS) has taken note of the announcement by the Minister of Health, Dr Joe Phaahla, in the Government Gazette on 22 June 2022, in which COVID-19 regulations were repealed.

Minister Phaahla stated that, as from 22 June, South Africans no longer have to wear masks, and that limits on gatherings and border checks for COVID-19, as well as the need to be vaccinated in order to enter South Africa, have also been dropped.

The UFS COVID-19 Regulations and Required Vaccination Policy has created an environment that the university management regards as safe. This, together with yesterday’s announcement by the Minister, was considered, and a decision was made that the wearing of masks on campus or in any building on campus is no longer compulsory.

However, the UFS COVID-19 Regulations and Required Vaccination Policy remains in place. Campus access control is still in place, and staff, students, and visitors are expected to upload a COVID-19 vaccination certificate or a negative PCR or antigen test result to obtain access to the campuses.

The wearing of masks is still recommended and will be of value especially in the following instances:

1.     For immune-compromised staff, students, and visitors
2.     For persons who are ill with, e.g., flu, colds, coughs, etc.

In the case of staff and students working in public and private hospitals, or any other external laboratory/facility, the wearing of masks is determined by the hospital or the external laboratory/facility and not by the UFS. In any other environment where students or staff are under the regulations of external organisations, these regulations will take precedence. 

Staff and students are encouraged to feel free to continue wearing masks, including those with comorbidities, as masks have been shown to be helpful in preventing the spread of respiratory diseases. Good health-care behaviour remains important as COVID-19 is still a reality.

The university management will decide in due course on the possible upliftment of restrictions on public gatherings.

Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept